Here’s why genetic testing can help you to detect some diseases
Tests using blood samples usually require a prescription, but saliva samples, which are less invasive than the first type, ask consumers to simply spit in a tube or swab the inside of their cheek.
Genetic markers if present, may signal susceptibilities to certain health conditions. These markers, called SNPs (or single nucleotide polymorphisms), are variations in gene sequences. SNPs don’t cause disease, but can help determine the chances of developing a certain illness.
Results indicating you’re at above-average risk for contracting a disease don’t guarantee you’ll get it, just as results showing no risk markers don’t mean you won’t. But for some, acting on the information like deciding to quit smoking or make diet changes may help prevent the disease’s development or lessen its effects.
Here’s some disease to be detected through genetic testing.
Breast and ovarian cancer
The vast majority of the more than 200,000 breast cancer diagnoses given to American women each year occur in those with no known family history of the disease, but 5 to 10 percent are due to up to three genetic mutations in the BRCA1 or BRCA2 genes.
BRCA genes belong to a class known as tumor suppressors. When mutated, they can allow uncontrolled cell growth. Women with mutations in these genes are about five times more likely to develop breast cancer than those without them, and are between 15 and 40 times more likely to develop ovarian cancer.
An autoimmune condition triggered by proteins called gluten that are found in wheat, barley and rye, celiac disease attacks the tissues of the small intestine, causing diarrhea and abdominal pain. About 2 million Americans are affected.
Many people with celiac disease have no symptoms, however, and the condition can mimic others such as irritable bowel syndrome. The only treatment is to stick to a gluten-free diet, which prevents intestinal damage.
Celiac disease is up to 87 percent attributable to genetics. Tests look for specific versions of genes for an immune system protein called HLA-DQ. The protein is encoded by a set of genes on chromosome 6.
About 1 in 22 people with a sibling, parent or child with celiac disease will develop it themselves. Those with a second-degree relative (an aunt, uncle, niece, nephew, grandparent, grandchild or half-sibling) have a 1 in 39 risk.
Also known as manic-depressive disorder, bipolar disorder is a mental illness marked by severe mood swings from despair to euphoria. Bipolar disorder affects 5.7 million Americans ages 18 and older, in any given year.
Bipolar disorder has a strong genetic component, though the SNPs that researchers have identified so far account for only a fraction of cases. Up to 93 percent of cases may be triggered by heredity,
Tests look for a protein marker encoded by the ANK3 gene, which is involved in nerve cell structure and function.
The average person’s chances of developing bipolar disorder are 2 to 3 percent,. The risks increase with the number of relatives affected and their degree of relatedness: up to 70 percent if an identical twin is affected, 50 percent if both parents have the disorder, 20 percent if one parent and a sibling has it, and 13 percent if a single sibling has it.
Those with a mutation on a gene called Fat, located on chromosome 4, appear to be at twice the risk of developing bipolar as the average person, though scientists aren’t yet sure why.
About one-third of Americans are classified as obese, meaning they weigh at least 100 pounds more than their ideal weight or have a body mass index (BMI) of 30 or higher.
Scientists don’t yet know how many genes are involved in developing obesity.
Variations in a gene called FTO gene account for almost 7 pounds of weight difference. A recent study also showed that levels of the FTO gene were higher in fatty tissue and the SNP on the FTO gene seems almost exclusively associated with fat tissue rather than muscle mass or bone density.
A neurological disorder caused by a loss of dopamine-producing brain cells, Parkinson’s disease is marked by trembling in the limbs, jaw and face; stiffness in the limbs and trunk; and or slowed movement and impaired balance and coordination. At least 500,000 Americans have been diagnosed with PD, with another 50,000 diagnosed each year.
Most cases of PD affect those over 50, and the average lifetime risk of developing it is small about 1 to 2 percent. However, mutations in a gene known as LRRK2 have been linked to a much higher risk of developing PD.
More than 50 variations of the LRRK2 gene are known, and several are associated with PD. A recent study found that a person who inherits a one mutation in this gene, called the G2019S mutation, from either parent has a 28 percent chance of developing Parkinson’s by age 59 and a 74 percent chance by age 79.
The most prevalent autoimmune condition in the United States, psoriasis affects as many as 7.5 million Americans, more than 2 percent of the population.
Characterized by red, scaly lesions that can cover any part of the body, psoriasis is up to 80 percent attributable to genetics and occurs when immune cells known as T-cells attack the skin.
Variations in a gene called HLA-C are associated with psoriasis, and studies have shown that seven other DNA variations are linked to the disease. However, environmental triggers appear to be necessary for psoriasis to develop, and only 10 percent of patients with variations in their HLA do so.
Age-related macular degeneration (AMD)
AMD is the most common cause of irreversible vision loss in Americans over age 60. The disease causes the retina, the tissue at the back of the eye responsible for transmitting images to the brain to deteriorate, resulting in central vision loss crucial for reading, driving or recognizing faces.
About 1.75 million Americans suffer from AMD. About 200,000 people lose central vision in one or both eyes each year.
Genetics and environmental factors account for the development of AMD with up to 71 percent of cases attributable to heredity. Tests focus on a group of genes called ABCR genes, and those with these certain variations in these genes have a 30 percent greater chance of developing AMD.
Those whose siblings have AMD are between three and six times more likely to develop it than the general population.